Author:
Jiang Hua,Dong Qiongna,Luo Xiaoying,Shi Bizhi,Wang Huamao,Gao Huiping,Kong Juan,Zhang Jiqin,Li Zonghai
Funder
Supporting Program of the “Twelfth Five-year Plan” for Science & Technology Research of China
Key Program of the Shanghai Science and Technology Committee
Shanghai Rising-Star Program (A type)
National Natural Science Foundation
Specialized Research Fund for the Doctoral Program of Higher Education
State Key Laboratory of Oncogenes and Related Genes
Reference39 articles.
1. Novel advancements in the management of hepatocellular carcinoma in 2008;Llovet;J. Hepatol.,2008
2. Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression;Shen;J. Cell Sci.,1991
3. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?;Zhu;Oncologist,2006
4. Molecular targeted therapy for hepatocellular carcinoma;Thomas;J. Gastroenterol.,2009
5. Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-kappaB activation;Zhang;Oncol. Rep.,2011
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献